Coastal Detox of Southern California
Medication can be an essential, evidence-based component of addiction treatment. Substance use disorders alter brain chemistry, biological responses, and stress pathways. Utilizing appropriate, FDA-approved medications helps reduce physiological distress, ease severe cravings, and normalize central nervous system function so patients can actively engage in their personal recovery journey.
Different medications perform distinct clinical functions. Some stabilize brain chemistry during acute withdrawal, while others block the rewarding effects of substances or minimize ongoing cravings during long-term rehabilitation. Because every person’s medical background, substance history, and health goals are unique, Coastal Detox provides individualized medical management rather than relying on a rigid or standard medication template.
Coastal Detox does not facilitate ongoing methadone maintenance dispensing. However, for people currently taking methadone who desire a medically supervised taper or a planned transition to another treatment pathway, our medical team can evaluate clinical appropriateness and provide structured residential oversight.
At Coastal Detox, medication management is never a standalone solution. We integrate medical care seamlessly with comprehensive individual therapy, evidence-based behavioral healthcare, dual-diagnosis treatment, and structured residential living.
Medication-assisted treatment (MAT)—also referred to as medication for opioid use disorder (MOUD) or medication for alcohol use disorder (MAUD)—is a whole-person approach to substance use disorder care. It combines clinical pharmacology with behavioral therapies, counseling, and recovery support services.
Substance dependence creates physical adaptation in the brain’s receptor systems. When a person stops using drugs or alcohol, these adaptations can cause intense physical discomfort and overwhelming cravings. MAT works by binding to these same neurological receptors, either activating them partially to prevent severe withdrawal or blocking them to prevent substances from producing a euphoric effect.
By relieving physical pain and calming persistent urges, medication provides a stable foundation. This enables patients to direct their energy toward psychological healing, processing underlying trauma, learning healthy coping strategies, and restoring their personal lives.
Clinical pharmacology in addiction care falls into two primary categories:
Recovery is not a uniform process, and there is no single medication strategy that fits every patient. A medication regimen that benefits one person may not be clinically appropriate for another.
Factors such as the specific substance used, duration of dependence, overall physical health, co-occurring mental health conditions, and individual treatment goals determine the most effective approach. Clinical decision-making must always be tailored to the individual.
FDA-approved medications for opioid use disorder (OUD) include buprenorphine, methadone, and naltrexone. These medications operate through distinct pharmacological mechanisms to restore balance to the brain’s opioid receptors.
Coastal Detox does not provide ongoing methadone maintenance treatment. However, our medical team can work with people who are taking methadone and want to explore medically supervised tapering or transition to another treatment option.
Federal guidelines established by agencies such as the Substance Abuse and Mental Health Services Administration (SAMHSA) regulate how these medications are accessed. Methadone for OUD is dispensed exclusively through federally certified Opioid Treatment Programs (OTPs). In contrast, medications like buprenorphine and naltrexone can be prescribed and managed in qualified residential, outpatient, or primary care medical settings, including Coastal Detox of Southern California.
Buprenorphine is a partial opioid agonist and a core tool in modern opioid use disorder treatment.
Because it is a partial agonist, buprenorphine activates opioid receptors in the brain sufficiently to quiet cravings and suppress withdrawal symptoms, but without producing the intense euphoria or severe respiratory depression associated with full opioid agonists like heroin or fentanyl. Buprenorphine has a “ceiling effect,” meaning its pharmacological impact levels off at higher doses, which enhances safety.
Buprenorphine is frequently formulated in combination with naloxone (commonly known by the brand name Suboxone). Naloxone is an opioid antagonist included to deter misuse. If the medication is taken sublingually as prescribed, the naloxone remains largely inactive. However, if the medication is injected, the naloxone blocks opioid receptors and precipitates withdrawal.
Buprenorphine can be utilized both for acute withdrawal stabilization during detox and as an ongoing maintenance therapy to support long-term recovery.
Naltrexone is an opioid antagonist used in the treatment of both opioid use disorder (OUD) and alcohol use disorder (AUD).
Unlike agonist medications, naltrexone does not activate opioid receptors at all. Instead, it binds tightly to these receptors and blocks them completely. If a person takes an opioid while on naltrexone, the drug cannot attach to the receptors, preventing any feelings of euphoria or pain relief. In alcohol treatment, naltrexone disrupts the neurochemical reward pathways that make drinking pleasurable, helping to reduce overall alcohol cravings and frequency of use.
Naltrexone is available as a daily oral tablet or as a long-acting monthly injectable (brand name Vivitrol). Because naltrexone completely blocks opioid receptors, the patient must be fully detoxed and free from all opioids for a clinical window before starting treatment to prevent initiating sudden, severe withdrawal.
Methadone is a long-acting, full opioid agonist that has been used for decades to treat opioid use disorder. It occupies opioid receptors fully, preventing withdrawal symptoms and reducing cravings without causing rapid spikes in euphoria when taken as prescribed.
Many people thrive on long-term methadone maintenance, maintaining physical stability, employment, and personal health for years. Clinical guidance from the American Society of Addiction Medicine (ASAM) recognizes long-term methadone maintenance as an effective standard of care.
However, some people eventually decide to reduce their dose, taper off the medication, or transition to a different treatment option, such as buprenorphine or naltrexone. Because methadone accumulates in bodily tissue and has a long half-life, adjusting or discontinuing a methadone regimen requires careful medical planning, individualized dose adjustments, and ongoing clinical oversight. Coastal Detox provides specialized medical support for appropriate patients seeking to navigate this transition safely.
Deciding to explore methadone tapering or medication transition is a personal choice that should be made in consultation with healthcare professionals. Patients consider changing their methadone regimen for various clinical and personal reasons:
Exploring a taper does not mean methadone was an incorrect choice. Rather, it reflects changing clinical needs and personal priorities.
Methadone tapering is the process of gradually reducing a person’s daily dose to minimize physical discomfort and maintain psychological stability.
A safe, medically supervised methadone taper involves:
Switching from methadone to buprenorphine requires precise medical management. Because buprenorphine has a stronger affinity for opioid receptors than methadone but only partially activates them, introducing buprenorphine while significant amounts of methadone remain in the body can displace the methadone and trigger severe, sudden withdrawal, a situation known as precipitated withdrawal.
Under guidelines from SAMHSA and ASAM, this transition typically requires slowly tapering the methadone dose down to a lower level before holding the dose, waiting for mild-to-moderate withdrawal symptoms to appear, and then carefully initiating buprenorphine under direct clinical supervision.
Transitioning from methadone to naltrexone requires a different clinical timeline. Because naltrexone is a total opioid antagonist, any residual methadone in the patient’s system will lead to acute withdrawal if naltrexone is introduced too early.
To safely transition to oral naltrexone or injectable Vivitrol, a patient must first taper off methadone completely and remain free of all opioids for a specified washout period, verified via urinalysis, before the first dose of naltrexone is administered.
Tapering off a full opioid agonist is a complex physical and psychological process. If a patient experiences significant withdrawal distress, intense cravings, or heightened risk of return to substance use during a taper, this is not a treatment failure.
Per SAMHSA clinical guidance, dose reductions should be re-evaluated whenever stability is compromised. The medical team may pause the taper, temporarily increase the dose to restore comfort, or reconsider the long-term medication plan. The primary goal of addiction treatment is patient health, safety, and stability—not achieving a medication-free status at the expense of well-being.
Naltrexone is a primary pharmacotherapy for alcohol dependence. By blocking endorphin receptors, it reduces the rewarding feelings associated with alcohol consumption. It is effective at helping patients reduce heavy drinking days and maintain long-term abstinence when combined with therapy.
Acamprosate (Campral) works differently by stabilizing neurochemical balance in the brain, specifically restoring equilibrium between gamma-aminobutyric acid (GABA) and glutamate pathways. Chronic alcohol use suppresses glutamate. When drinking stops, glutamate hyper-excitability can cause persistent restlessness, anxiety, and sleep disturbances. Acamprosate mitigates these chronic withdrawal symptoms, making it easier for patients who have already achieved sobriety to remain alcohol-free.
Disulfiram (Antabuse) serves as a deterrent medication. It interferes with how the liver metabolizes alcohol, leading to an accumulation of acetaldehyde if alcohol is consumed. This causes unpleasant physical reactions, including facial flushing, nausea, headache, and rapid heart rate. Disulfiram does not reduce cravings directly. Instead, it provides a physical incentive to avoid drinking.
There’s an important distinction between medications used during acute medical detox and ongoing medication-assisted treatment.
During initial detox, short-term medications are administered to:
Detox medications may include short-term tapers of supportive agents, anti-nausea medications, muscle relaxants, or non-narcotic sedatives designed specifically for acute physical stabilization.
Once acute withdrawal is successfully managed, the medical team evaluates whether transitioning to an ongoing MAT medication (such as buprenorphine or naltrexone) is clinically appropriate for long-term maintenance. Detox focuses on immediate physical safety, while MAT provides ongoing stabilization.
Medication is most effective when integrated into a comprehensive, structured residential care framework. At Coastal Detox, medication management is one component of a broader, whole-person recovery strategy.
Our residential program combines medical oversight with evidence-based behavioral therapies:
Combining clinical pharmacology with structured residential therapy ensures that physical stability is supported by genuine psychological healing.
MAT/MAUD may be appropriate for people who:
MAT/MOUD may be appropriate for people who:
Rather than using standardized, pre-set protocols, Coastal Detox designs medication plans through shared clinical decision-making between the patient and our medical team.
Our personalization process evaluates ten key clinical factors:
Coastal Detox is dedicated to providing a safe, compassionate, and supportive environment where patients are met with dignity and guided with expert care through every stage of the treatment journey.
Comprehensive intake assessment reviewing physical health, psychiatric history, and substance use patterns.
24/7 medical oversight during acute withdrawal management in a comfortable, home-like setting.
Initiating and fine-tuning appropriate medication protocols based on real-time clinical response.
Transitioning into daily structured programming, living in a quiet coastal environment free from external triggers.
Participating in daily individual, group, CBT, and dual-diagnosis counseling sessions.
Developing a step-down continuing care plan, including outpatient prescriptions, local therapy connections, and recovery resources.
For patients entering Coastal Detox specifically to taper off methadone or transition to another medication, we offer a dedicated, compassionate pathway tailored to your unique clinical needs. Stepping down from a long-term methadone routine requires specialized care and continuous monitoring. From your initial arrival through ongoing stabilization, our multidisciplinary medical team guides you through each distinct stage of the tapering process to ensure your safety, well-being, and long-term peace of mind.
Medication-assisted treatment may be right for you if you are seeking to manage cravings and withdrawal from opioids or alcohol. The supportive residential environment at Coastal Detox of Southern California can help you reach your recovery goals, whether that’s starting MAT for the first time, transitioning to a different medication regimen to better support your needs, or returning to rehab after experiencing a relapse.
You don’t have to make these clinical decisions alone. The medical and clinical staff at Coastal Detox are available to answer your questions, evaluate your health history, and help you determine whether medication-assisted treatment fits into your broader recovery plan. Call our admissions line today for a free, no-obligation consultation.
Medication-assisted treatment (MAT) is an evidence-based approach to addiction care that combines FDA-approved medications with behavioral therapy, counseling, and medical supervision to help manage withdrawal symptoms, reduce cravings, and support long-term recovery.
The primary FDA-approved medications for opioid use disorder are buprenorphine (such as Suboxone), naltrexone (such as Vivitrol), and methadone. Each medication works differently to stabilize brain chemistry and reduce opioid cravings or block opioid effects.
No, Coastal Detox does not provide ongoing methadone maintenance dispensing or operate as an Opioid Treatment Program (OTP).
Yes, for clinically appropriate patients who are currently taking methadone and wish to reduce their dose or switch pathways, Coastal Detox provides medically supervised support for methadone tapering and transition as part of an individualized residential treatment plan.
Yes, under clinical evaluation and structured medical oversight, patients can transition from methadone to buprenorphine. This process involves gradually tapering the methadone dose down and carefully timing the first buprenorphine dose to prevent precipitated withdrawal.
There is no standard or fixed timeline for tapering off methadone. The duration depends on your starting dose, how long you have taken it, physical health, individual response, and personal stability. Tapering schedules are adjusted based on how you feel rather than a rigid calendar.
No, stopping methadone abruptly can trigger severe, prolonged physical withdrawal, intense psychological distress, and a heightened risk of return to drug use. Any reduction or discontinuation of methadone should always be conducted under professional medical supervision.
No, MAT is not just replacing one addiction with another. Addiction is characterized by compulsive drug search, loss of control, and harmful behaviors despite negative consequences. When taken as prescribed, MAT medications normalize brain function, relieve physiological distress, and restore mental stability without producing euphoria or intoxicating highs.
Yes, MAT is frequently integrated into residential addiction treatment programs, allowing patients to receive 24/7 medical oversight and medication management while fully participating in daily therapy, counseling, and holistic recovery services.
Yes, medications such as naltrexone, acamprosate, and disulfiram are FDA-approved for alcohol use disorder. They work by blocking the euphoric rewards of drinking, stabilizing brain chemistry altered by alcohol, or creating a physical deterrent to alcohol consumption.
The duration of MAT varies entirely based on individual needs and health goals. Some patients utilize short-term medication protocols during detox and early rehabilitation, while others remain on ongoing maintenance medications for months, years, or indefinitely under medical supervision to maintain stability and prevent relapse.
Kay Saffe, LPCC, is a Licensed Professional Clinical Counselor and Clinical Director at Coastal Detox of Southern California. She holds a Master’s Degree in Clinical Mental Health Counseling from the University of San Diego and a Bachelor’s Degree in Psychology from New College of Florida. She has been in recovery for over 4 years and is passionate about using positive psychology to help others through their own recovery journey. Outside of Coastal Detox, Kay also works as a surf instructor and volunteers with local San Diego non-profits to help treat at-risk individuals in both English and Spanish. Originally from Miami, Florida, Kay is a first-generation American with Argentinian heritage.
Contact Us Today for a Free Confidential Assessment and Insurance Verification.
"*" indicates required fields
